JANUS HENDERSON GROUP PLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 161 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANUS HENDERSON GROUP PLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$17,999,452
-19.3%
1,141,373
-0.6%
0.01%
-14.3%
Q2 2023$22,312,642
-31.5%
1,147,771
-0.1%
0.01%
-33.3%
Q1 2023$32,580,905
-9.4%
1,148,429
-6.6%
0.02%
-19.2%
Q4 2022$35,949,061
+9.6%
1,229,872
-50.4%
0.03%
+4.0%
Q3 2022$32,788,756
-48.7%
2,479,558
+72.5%
0.02%
-43.2%
Q2 2022$63,860,000
-13.1%
1,437,314
-3.2%
0.04%
+25.7%
Q1 2022$73,512,000
-5.5%
1,485,404
-2.8%
0.04%
+9.4%
Q4 2021$77,814,000
-8.6%
1,528,152
+0.1%
0.03%
-13.5%
Q3 2021$85,182,000
+30.0%
1,527,102
-0.2%
0.04%
+32.1%
Q2 2021$65,504,000
-1.3%
1,530,477
-3.8%
0.03%
-6.7%
Q1 2021$66,396,000
-15.8%
1,590,710
-6.1%
0.03%
-18.9%
Q4 2020$78,893,000
+9.3%
1,694,073
-0.3%
0.04%
-2.6%
Q3 2020$72,162,000
-11.9%
1,698,737
-0.5%
0.04%
-17.4%
Q2 2020$81,885,000
+1.2%
1,706,644
-3.0%
0.05%
-17.9%
Q1 2020$80,937,000
-25.1%
1,759,494
-2.2%
0.06%
+1.8%
Q4 2019$108,127,000
+8.2%
1,799,709
+1.9%
0.06%
+1.9%
Q3 2019$99,891,000
+1.5%
1,765,800
-0.1%
0.05%
+1.9%
Q2 2019$98,451,000
+10.0%
1,768,154
-0.3%
0.05%
+6.0%
Q1 2019$89,531,000
+23.8%
1,773,252
-1.2%
0.05%
+8.7%
Q4 2018$72,339,000
-44.5%
1,795,462
-4.6%
0.05%
-34.3%
Q3 2018$130,444,000
-8.8%
1,881,501
-0.5%
0.07%
-14.6%
Q2 2018$143,096,000
+42.5%
1,891,298
-0.8%
0.08%
+39.0%
Q1 2018$100,446,000
+13.2%
1,906,360
+14.8%
0.06%
+7.3%
Q4 2017$88,724,000
-17.7%
1,660,881
-8.1%
0.06%
-20.3%
Q3 2017$107,782,000
-25.4%
1,807,202
-1.3%
0.07%
-29.6%
Q2 2017$144,384,0001,830,1990.10%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 4,780,188$353,877,00083.76%
JW Asset Management, LLC 848,709$62,830,00022.76%
Consonance Capital Management LP 1,353,913$100,230,00014.10%
Cormorant Asset Management, LP 300,000$22,209,0003.55%
Park West Asset Management LLC 500,591$37,059,0003.38%
Opaleye Management Inc. 73,200$5,419,0002.67%
Ranger Investment Management 428,295$31,707,0001.79%
WALL STREET ASSOCIATES 119,900$8,876,0001.70%
Timpani Capital Management LLC 27,090$2,005,0000.81%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 22,375$1,656,0000.79%
View complete list of EAGLE PHARMACEUTICALS INC shareholders